COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02296918
Brief Title: Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

First Submitted : November 19, 2014
First Submitted that Met QC Criteria : November 20, 2014
First Posted : November 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 17, 2019
Last Update Posted : September 18, 2019